Vimarsana
Biggest News Aggregation in the World

Page 15 - Precigen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Precigen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Precigen Today - Breaking & Trending Today

Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments - Vimarsana News

Precigen to Host R&D Update Virtual Event on November 4th to Share Clinical Developments

Published: October 27, 2021

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Jamesl GulleyDavid SallmanMaryl Nora DisisSteven HarasymHelen SabzevariClintt AllenUw CenterH Lee Moffitt Cancer Center Research InstituteNational Institutes Of HealthUniversity Of Washington Uw Professor MedicineExchange CommissionOncology ServiceDepartment Of Malignant HematologyClinical Research Division At Fred HutchPrecigen IncTranslational MedicineClinical Research DivisionFred HutchAssistant MemberMalignant HematologyMoffitt Cancer CenterResearch InstituteBranch ChiefMedical Oncology ServiceNational Institutes
Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors - Vimarsana News

Precigen Announces Clearance of IND to Initiate Phase 1/1b Study for PRGN-3007 UltraCAR-T® in Advanced ROR1+ Hematological and Solid Tumors

Published: October 26, 2021

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Precigen UltraHatem SolimanSteven HarasymJavier Pinilla IbarzHelen SabzevariMalignant Hematology DepartmentH Lee Moffitt Cancer Center Research InstituteDrug AdministrationExchange CommissionPrnewswire Precigen IncPrecigen IncClinical Trials OfficeInvestigational New DrugMoffitt Cancer CenterSenior MemberLymphoma Section HeadResearch InstitutePrincipal InvestigaMedical DirectorReceptor Tyrosine Kinase Like OrphanAdvancing MedicineStatement Regarding Forward Looking StatementsAnnual ReportHuman CancerClin Cancer Res
Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer - Vimarsana News

Precigen Appoints Harry Thomasian Jr. as Chief Financial Officer

Published: October 12, 2021

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
United StatesNorth CarolinaHarry Thomasian JrSteven HarasymHelen SabzevariKellogg School Of ManagementSenior Client Services PartnerBentley UniversityErnst Young Executive Development ProgramBaltimore Office Growth Markets LeaderEy Capital Markets CenterExchange CommissionErnst YoungNorthwestern UniversityPrecigen IncHarry ThomasianSenior PartnerMarkets CenterYoung Executive Development ProgramKellogg SchoolState BoardsAdvancing MedicineStatement Regarding Forward Looking StatementsAnnual Report
Vertex, Incyte fall; Precigen, Magnachip rise - Vimarsana News

Vertex, Incyte fall; Precigen, Magnachip rise

Published: June 11, 2021

NEW YORK (AP) — Stocks that traded heavily or had substantial price changes...

Source: sfgate.com
Related Topics:
Instruments IncDave Buster Entertainment IncMagnachip Semiconductor CorpIncyte CorpDigital CorpRoyal Caribbean GroupPrecigen IncEntertainment IncSemiconductor CorpSouth DearbornCornucopia InvestmentCaribbean GroupCelebrity MillenniumDave AmpNew YorkSouth DearbornIncyte CorpC Complete State NationalMks Instruments IncWestern Digital CorpUsters Entertainment Inc Cornucopia Investment PartnersRoyal Caribbean GroupC Plus AgateUsiness News
Precigen to Present at the JMP Securities Life Sciences Conference - Vimarsana News

Precigen to Present at the JMP Securities Life Sciences Conference

Published: June 10, 2021

/PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the...

Source: prnewswire.com
Related Topics:
Steven HarasymHelen SabzevariExchange CommissionSecurities Life Sciences Conference OnPrecigen IncLife Sciences ConferenceAdvancing MedicineAnnual ReportHealth Care Amp HospitalsMedical Pharmaceuticalsபரிமாற்றம் தரகுவாழ்க்கை அறிவியல் மாநாடுஆண்டு அறிக்கைஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள்மருத்துவ மருந்துகள்உயிரி தொழில்நுட்பவியல்